|
Seroquel Tied to Deaths 
The New York Times | April 12, 2005
Older patients with dementia who are given antipsychotic medicines are far more likely
to die prematurely than those given dummy pills, federal drug regulators said Monday.
The warning adds to growing worries about the safety of the widely prescribed drugs.
The Food and Drug Administration said that it would now require manufacturers of the
medicines to place black-box warnings—the agency's most severe—on the labels
of all the drugs. In 2003, the agency required manufacturers to add a warning about an
increased risk of diabetes from antipsychotic medications.
Zyprexa and Sympyax from Eli Lilly, Risperda from Johnson & Johnson, Seroquel from AstroZeneca,
Abilify from Bristol-Myers Squibb, Clozaril from Novartis and Geodon from Pfizer are
all affected by the warning. |